Reports related to this article:
Project(s): View 6 related projects in PECWeb
Plant(s): View 4 related plants in PECWeb
Released March 06, 2025 | SUGAR LAND
en
Researched by Industrial Info Resources (Sugar Land, Texas)--While drugs often take center stage when talking about the medical sector, medical devices that aid physicians with things like drug delivery and surgical procedures also represent an important component in medicine. Industrial Info is tracking more than $6.5 billion worth of active construction plans for the manufacture of medical devices. North Carolina, home to a strong life sciences sector in its Research Triangle region around Raleigh, Durham and Chapel Hill, leads in terms of spending.
Among the projects presently underway in North Carolina is Nipro Medical Corporation's (Bridgewater, New Jersey) first North American manufacturing facility in Greenville, North Carolina. The facility is set to produce supporting devices such as dialyzers and precision needles for patients with diabetes, chronic kidney disease and other renal health issues. The first phase of construction, which kicked off a few months ago, includes building a 150,000-square-foot building with supporting equipment and is expected to be completed in early 2027. Before that completion, however, Nipro may have already jumped into a Phase II expansion project, which is slated to begin later this year and includes a 500,000-square-foot building that could be finished some months after the completion of the initial plant. The move cuts down on the distances Nipro must ship its products, thus reducing carbon emissions from the shipping process. Tsuyoshi Yamazaki, senior managing director of global business at Nipro, said, "Our close proximity to customers will allow us to better respond to their needs and provide them with timely and effective solutions." Subscribers to Industrial Info's Global Market Intelligence (GMI) Project Database can learn more by viewing the related project reports.
Solutions for injecting drugs are another strong component of the medical devices sector, and PCI Pharma Services (Philadelphia, Pennsylvania) hopes to help fill this niche as it fits out a portion of a newly constructed building in Rockford, Illinois, with multiformat machines for the assembly and packaging of vials, prefilled syringes, autoinjectors and pen-cartridge combinations. The company's website said the equipment can be used for today's popular GLP-1 drugs prescribed for diabetes and obesity as well as for treatments of cancer and autoimmune disorders. The project is expected to be completed toward of summer 2026. Subscribers can click here to learn more about the project.
Tapes and dressings represent important components in the treatment of both accidental wounds and surgical incisions. 3M spinoff Solventum Corporation (Saint Paul, Minnesota) is addressing this issue in a project that is about halfway through its three-year construction timeline. General contractor Clark Drew Construction Incorporated (Brookings, South Dakota) is in the process of building out a 200,000-square-foot building that includes manufacturing space, wet labs, shipping docks and warehousing for the production of surgical supplies such as tapes, films and dressings. The project kicked off in late 2023 and is expected to be completed toward the end of next year. Subscribers can click here for more details of the project.
Hearing aids are another important medical device receiving attention in the U.S. The U.S. division of GN Group (Copenhagen, Denmark) is relocating its North American headquarters and manufacturing facility from Bloomington, Minnesota, to Shakopee, Minnesota, later this year. As the company prepares for the move, it is renovating and fitting out a 218,000-square-foot building that will house production, repairs and shipping of hearing aids, along with office space. "We've simply outgrown our current space," said Tom Woods, president of the GN Hearing division in North America. The move will bring a 79% increase in space from the Bloomington facility. Additionally, the facility is expandable by 118,000 square feet should future growth warrant it. The project is expected to be completed this summer. Subscribers can learn more by viewing the project report.
Subscribers to Industrial Info's GMI Database can click here to view reports for all of the projects discussed in this article and click here for the related plant profiles.
Industrial Info Resources (IIR) is the leading provider of industrial market intelligence. Since 1983, IIR has provided comprehensive research, news and analysis on the industrial process, manufacturing and energy related industries. IIR's Global Market Intelligence (GMI) helps companies identify and pursue trends across multiple markets with access to real, qualified and validated plant and project opportunities. Across the world, IIR is tracking over 200,000 current and future projects worth $17.8 trillion (USD).
Among the projects presently underway in North Carolina is Nipro Medical Corporation's (Bridgewater, New Jersey) first North American manufacturing facility in Greenville, North Carolina. The facility is set to produce supporting devices such as dialyzers and precision needles for patients with diabetes, chronic kidney disease and other renal health issues. The first phase of construction, which kicked off a few months ago, includes building a 150,000-square-foot building with supporting equipment and is expected to be completed in early 2027. Before that completion, however, Nipro may have already jumped into a Phase II expansion project, which is slated to begin later this year and includes a 500,000-square-foot building that could be finished some months after the completion of the initial plant. The move cuts down on the distances Nipro must ship its products, thus reducing carbon emissions from the shipping process. Tsuyoshi Yamazaki, senior managing director of global business at Nipro, said, "Our close proximity to customers will allow us to better respond to their needs and provide them with timely and effective solutions." Subscribers to Industrial Info's Global Market Intelligence (GMI) Project Database can learn more by viewing the related project reports.
Solutions for injecting drugs are another strong component of the medical devices sector, and PCI Pharma Services (Philadelphia, Pennsylvania) hopes to help fill this niche as it fits out a portion of a newly constructed building in Rockford, Illinois, with multiformat machines for the assembly and packaging of vials, prefilled syringes, autoinjectors and pen-cartridge combinations. The company's website said the equipment can be used for today's popular GLP-1 drugs prescribed for diabetes and obesity as well as for treatments of cancer and autoimmune disorders. The project is expected to be completed toward of summer 2026. Subscribers can click here to learn more about the project.
Tapes and dressings represent important components in the treatment of both accidental wounds and surgical incisions. 3M spinoff Solventum Corporation (Saint Paul, Minnesota) is addressing this issue in a project that is about halfway through its three-year construction timeline. General contractor Clark Drew Construction Incorporated (Brookings, South Dakota) is in the process of building out a 200,000-square-foot building that includes manufacturing space, wet labs, shipping docks and warehousing for the production of surgical supplies such as tapes, films and dressings. The project kicked off in late 2023 and is expected to be completed toward the end of next year. Subscribers can click here for more details of the project.
Hearing aids are another important medical device receiving attention in the U.S. The U.S. division of GN Group (Copenhagen, Denmark) is relocating its North American headquarters and manufacturing facility from Bloomington, Minnesota, to Shakopee, Minnesota, later this year. As the company prepares for the move, it is renovating and fitting out a 218,000-square-foot building that will house production, repairs and shipping of hearing aids, along with office space. "We've simply outgrown our current space," said Tom Woods, president of the GN Hearing division in North America. The move will bring a 79% increase in space from the Bloomington facility. Additionally, the facility is expandable by 118,000 square feet should future growth warrant it. The project is expected to be completed this summer. Subscribers can learn more by viewing the project report.
Subscribers to Industrial Info's GMI Database can click here to view reports for all of the projects discussed in this article and click here for the related plant profiles.
Industrial Info Resources (IIR) is the leading provider of industrial market intelligence. Since 1983, IIR has provided comprehensive research, news and analysis on the industrial process, manufacturing and energy related industries. IIR's Global Market Intelligence (GMI) helps companies identify and pursue trends across multiple markets with access to real, qualified and validated plant and project opportunities. Across the world, IIR is tracking over 200,000 current and future projects worth $17.8 trillion (USD).
